Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With Hepatitis B Cirrhosis and AKI

Urinary Neutrophil Gelatinase-Associated Lipocalin Can Predict the Efficacy of Volume Expansion Therapy in Patients With Hepatitis B Cirrhosis and AKI

Backgrounds: Kidney biomarkers in urine appear to be useful in differential diagnosis between acute tubular necrosis and other types of acute kidney injury (AKI) in cirrhosis. In clinical practice, prerenal azotemia (PRA) is often distinguished from other types of AKI by volume expansion therapy. Th...

Full description

Bibliographic Details
Main Authors: Zhonghui Duan, Minjie Jiang, Xiaojie Huang, Haixia Liu, Hongwei Yu, Qinghua Meng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Pharmacology
Subjects:
cirrhosis
kidney injury
urinary biomarker
diagnostic marker
NGAL
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.839250/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.839250/full

Similar Items